INFUSYSTEM HOLDINGS, INC Property, Plant and Equipment
INFUSYSTEM HOLDINGS, INC (INFU) had Property, Plant and Equipment of $3.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-04
- 2026-06-30: Property, Plant and Equipment, Net $3.00M.
- 2026-03-31: Property, Plant and Equipment, Net $3.22M.
- 2025-12-31: Property, Plant and Equipment, Net $3.36M.
- 2025-09-30: Property, Plant and Equipment, Net $3.65M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $3.22M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $3.36M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $3.65M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $3.81M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $3.92M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $4.03M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $3.91M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $4.17M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.23M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.32M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $4.23M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.30M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.39M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $4.38M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $4.21M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.31M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.38M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $4.52M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $4.43M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.32M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $4.33M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $4.30M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $4.29M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $4.42M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $4.38M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $4.04M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $2.85M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.54M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.37M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.45M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $1.49M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.54M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.55M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.63M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.71M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.81M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.91M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.00M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $2.14M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $2.24M 10-Q/A · filed 2016-12-12 | |
| 2016-03-31 | $2.31M 10-Q/A · filed 2016-12-12 | |
| 2015-12-31 | $2.37M 10-K · filed 2017-03-22 | |
| 2015-09-30 | $2.32M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.39M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $2.46M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $2.45M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $2.37M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.58M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $915.00K 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $872.00K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $813.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $798.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $848.00K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $867.00K 10-K · filed 2014-03-11 | |
| 2012-09-30 | $14.04M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $14.44M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $14.86M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $927.00K 10-K · filed 2013-03-28 | $15.76M 10-K · filed 2012-03-16 |
| 2011-09-30 | $16.88M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $16.93M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $16.67M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |